C

Cipla Ltd

Pharmaceuticals

LARGECAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 31 analysts offering recommendations for Cipla Ltd

71%

Buy

23%

Hold

6%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio28.8551.71
PB Ratio4.446.63
Dividend Yield0.88%0.52%

Understand what these metrics mean. 

About the company

C

Cipla Ltd

Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious disea...
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions